ANDA 75887, held by Upsher Smith Labs. Fluvoxamine Maleate.
As of Nov 16, 2026, ANDA 75887 (Fluvoxamine Maleate), held by Upsher Smith Labs, was first approved by FDA on Jan 5, 2001, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 5, 2001 | Original application | Approved |
| Fluvoxamine Maleate25MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Fluvoxamine Maleate50MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Fluvoxamine Maleate100MG · tablet;oral | Fluvoxamine Maleate | Discontinued |
| Aug 29, 2003 | Supplement 7Labeling | Approved | None posted |
| Nov 26, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Nov 26, 2001 | Supplement 2Manufacturing | Approved | None posted |
| Jan 5, 2001 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters